PTPN2 and inflammatory bowel disease: Of particular interest, we found that the presence of the disease-associated PTPN2 variant in patients from the Swiss IBD Cohort Study (SIBDCS) is associated with a more severe disease course, in particular increased frequency of pancolitis and intestinal surgery in UC patients, however a better treatment response to anti-TNF antibodies in both CD and UC patients [23].